New corticocuneate cellular mechanisms underlying the modulation of cutaneous ascending transmission in anesthetized cats.
The ascending cutaneous transmission through the middle cuneate nucleus is subject to cortico-feedback modulation. This work studied the intracuneate cellular mechanisms underlying the corticocuneate influence. Single unit extracellular records combined with iontophoresis showed that the corticocuneate input activates cuneo-lemniscal (CL) and noncuneo-lemniscal (nCL) cells via N-methyl-D-aspartate (NMDA) and non-NMDA receptors as shown by the decrease of the cortical-induced activation on ejection of CNQX and APV, either alone or in combination. These results were confirmed by in vivo intracellular recordings. Two subgroups of nCL cells were distinguished according to their sensitivity to iontophoretic ejection of glycine and its antagonist, strychnine. Finally, the corticalevoked activation of CL cells was decreased by GABA and increased by glycine acting at a strychnine-sensitive site, indicating that glycine indirectly affects the cuneo-lemniscal transmission. A model is proposed whereby the cortex influences CL cells through three different mechanisms, producing 1) activation via non-NMDA and NMDA receptors, 2) inhibition through GABAergic nCLs, and 3) disinhibition via serial glycinergic-GABAergic nCL cells. These corticocuneate feedback effects serve to potentiate the activity of CL cells topographically aligned through direct activation and disinhibition, while inhibiting, via GABAergic cells, other CL neurons not topographically aligned.
Aguilar
Juan
J
Department of Physiology, Faculty of Medicine, 15705 Santiago de Compostela, Spain.
Rivadulla
Casto
C
Soto
Cristina
C
Canedo
Antonio
A
D000200:Action Potentials; D000344:Afferent Pathways / Q000502:physiology; D000818:Animals; D002415:Cats; D002540:Cerebral Cortex / Q000166:cytology / Q000502:physiology*; D004594:Electrophysiology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005998:Glycine / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D018684:Glycine Agents / Q000494:pharmacology; D007395:Interneurons / Q000502:physiology; D007478:Iontophoresis; D009434:Neural Pathways / Q000502:physiology*; D009474:Neurons / Q000502:physiology*; D017470:Receptors, Glutamate / Q000502:physiology*; D012867:Skin / Q000294:innervation*; D013331:Strychnine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology / Q000502:physiology*
D018691:Excitatory Amino Acid Antagonists; D018684:Glycine Agents; D017470:Receptors, Glutamate; D005680:gamma-Aminobutyric Acid; D013331:Strychnine; D005998:Glycine